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SUMMARY
Cell death in the developing retina is regulated, but so far little is known about what factors regulate
the cell death. Several neurotrophic factors and receptors, including the neurotrophins and Trk
receptors, are expressed during the critical time. We have studied the developing avian retina with
respect to the role of nerve growth factor (NGF) in these processes. Our starting point for the work
was that NGF and its receptor TrkA are expressed in a partially overlapping pattern in the inner
nuclear layer of the developing retina. Our results show that TrkA and NGF-expressing cells are
postmitotic. The first NGF-expressing cells were found on the vitreal side of the central region of
E5.5–E6 retina. This pattern changed and NGF-expressing cells identified as horizontal cells were
later confined to the external inner nuclear layer. We show that these horizontal cells co-express
TrkA and NGF, unlike a subpopulation of amacrine cells that only expresses TrkA. In contrast to the
horizontal cells, which survive, the majority of the TrkA-expressing amacrine cells die during a
period of cell death in the inner nuclear layer. Intraocular injections of NGF protein rescued the dying
amacrine cells and injection of antisense oligonucleotides for NGF that block its synthesis, caused
death among the TrkA-expressing horizontal cells, which normally would survive. Our results
suggest that NGF supports the survival of TrkA expressing avian horizontal cells in an autocrine
mode of action in the retina of E10-E12 chicks. The cells co-express TrkA and NGF and the role for
NGF is to maintain the TrkA-expressing horizontal cells. The TrkA-expressing amacrine cells are
not supported by NGF and subsequently die. In addition to the effect on survival, our results suggest
that NGF plays a role in horizontal cell plasticity.
Keywords
Retina; Cell death; Horizontal cell; Amacrine cell; NGF; TrkA; Chick; BrdU
INTRODUCTION
Cells that undergo naturally occurring death has been found in the early and late developing
retina (Hughes and McLoon, 1979; Rager and Rager, 1978; Ulshafer and Clavert, 1979). Early
cell death in chick embryo occurs during formation of the optic cup (Cuadros and Rios,
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1988; Martín-Partido et al., 1988) and late death occurs after the time at which retinal neurones
have started to differentiate (Cook et al., 1998). Cells that die during the early period
(embryonic day (E)2–E4.5) are proliferating (Diaz et al., 1999), and are located in defined
regions of the neuroepithelium that are associated with bending and fusion of the lips of the
coroid fissure. The later period (E8–E16) starts in the central retina and proceeds towards the
peripheral parts following the general pattern of retinal development (Prada et al., 1991). The
distribution of dying cells is layer specific and the different classes of retinal neurones die
during specific and restricted times of this period (Cook et al., 1998). The specific timecourses
and patterns show that the extent of death and survival is strictly regulated.
Several neurotrophic factors and receptors including the neurotrophins and Trk receptors
(Lewin and Barde, 1996) are expressed in specific temporal and cellular patterns in the retina
during this period (Hallböök et al., 1996; von Bartheld, 1998). The nerve growth factor (NGF)
receptors TrkA and p75 are expressed in the developing retina: TrkA is expressed by horizontal
and amacrine cells (Karlsson et al., 1998), whereas p75 is expressed by several cell types in
the early and late retina (Hallböök et al., 1990; Karlsson et al., 1998; Large et al., 1989; von
Bartheld et al., 1991). Frade et al. have suggested that NGF can induce cell death via p75 during
the early cell death. NGF was suggested to be synthesised by microglia cells that migrate to
the early retina and present NGF to neurones that die (Frade and Barde, 1998; Frade and Barde,
1999; Frade et al., 1996). The cells that die do not express TrkA receptors. We have previously
shown that NGF mRNA levels increase after E6, and that the expression is located in the
external part of the inner nuclear layer (INL) at E18 (Hallböök et al., 1996). The increase of
NGF expression is coincident with the late cell death, and the localisation of NGF synthesis
corresponds to persisting TrkA-expressing horizontal cells. This pattern suggests that the NGF
synthesis supports the survival of the remaining TrkA-expressing horizontal cells.
In this work we have experimentally tested this hypothesis by blocking the endogenous
synthesis of NGF. We have characterised the cellular origin of NGF and TrkA expression, and
have studied whether the start of expression precedes or follows neuronal differentiation.
MATERIALS AND METHODS
Embryos and embryo culture
Fertilised White Leghorn eggs were incubated in a humidified incubator and embryos were
staged according to Hamburger and Hamilton (Hamburger and Hamilton, 1951). Retinas from
embryos older than E6 were dissected, whereas younger specimens were analysed as total
embryos. Embryos for injection (see below) were treated as petri dish cultures or were injected
in ovo (Selleck, 1996). For the embryo cultures, fertilised eggs incubated for 2.5 days were
cracked open aseptically and poured into sterile high wall petri dishes. The cultures were kept
at 37°C in a humidified incubator. The development of embryos in cultures can be slower than
that of embryos developing in ovo, so they were staged just before injections and analyses.
The stages were back translated to embryonic days (as indicated in the text).
In situ hybridisation analysis
Nonradioactive in situ hybridisation was performed on dissected whole retina. The procedure
was essentially performed as previously described (Nieto et al., 1996; Wilkinson, 1992). The
probes were digoxigenin- (DIG) and fluorescein-labelled antisense or sense riboprobes
corresponding to nucleotides 1009–1440 of the chicken TrkA receptor (Bäckström et al.,
1996), nucleotides 98–1054 of the chicken prepro-NGF gene (Ebendal et al., 1986) and
nucleotides 1266–2321 of the genomic sequence of chicken Brn3a (Lindeberg et al., 1997).
The TrkA probe spanned trans- and juxtamembrane regions. Tissue was fixed for 2–3 hours
in 4% paraformaldehyde in PBS (PFA), bleached in 3% H2O2 and treated with 20 μg/ml
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proteinase-K for 20 minutes. Retinas were then hybridised for 40 hours at 65–70°C. Probe
concentration was approximately 1 μg/ml for each probe. Alkaline phosphatase (AP)-
conjugated anti-DIG and anti-fluorescein antibodies were used to detect the probes. The AP
substrates nitroblue tetrazolium chloride (NBT, blue colour)/5-bromo-4-chloro-3-indolyl-
phosphate, 4-toluidine salt (BCIP) and 2-[4-iodophenyl]-3-[4-nitrophenyl]-5-phenyl
tetrazolium chloride (INT, red colour)/BCIP (Boehringer-Mannheim) were used and the tissue
was incubated for 1 to 4 days until desired reaction product intensity was achieved. When using
a single probe, NBT/BCIP was preferred and retinas were fixed before embedded in paraffin
wax and sectioned in a microtome. When two probes were hybridised, NBT/BCIP was used
with the first probe (DIG) and INT/BCIP with the second (fluorescein). The AP activity of the
DIG-antibody was blocked with 0.1 M glycine-HCl pH 2.2, 0.1% Tween-20 for 10 minutes
before addition of the AP-fluorescein antibody. The reaction product from INT/BCIP is not
stable in organic solvents and therefore the retinas were fixed, cryoprotected in 15–30%
sucrose, mounted in Tissue-Tek (Sakura, Tokyo, Japan) and cut using a cryostat (14 μm). These
sections were mounted in PBS before viewing in bright-field illumination microscopy.
BrdU incorporation in combination with in situ hybridisation and immunohistochemistry
analyses
Incorporation of 5-bromo-2′-deoxy-uridine (BrdU), was used to visualise cells passing the S-
phase of the cell cycle and was combined with in situ hybridisation for NGF mRNA. 100 μl
of 12 mg/ml BrdU (Sigma, St Louis, MO) was injected into the yolk sac of an embryo in culture
or in ovo. The shortest incubation time for effective and reproducible BrdU incorporation after
injection was titrated and found to be 12 hours. After BrdU incorporation, E6, E6.5, E7 and
E9 retinas were dissected, fixed in PFA and processed for in situ hybridisation. After colour
reaction with NBT/BCIP and fixation, the retinas were cryoprotected, cut using a cryostat and
processed for BrdU immunohistochemistry using a monoclonal anti-BrdU antibody (B-2531,
Sigma) diluted 1:500 in PBS; 3% of Triton-X100; 1% BSA and 5% horse serum. The sections
were incubated with a horseradish peroxidase-conjugated anti-mouse IgG (A-9309, Sigma)
diluted 1/200 in PBS. To visualise the secondary antibody, we used the peroxidase-3–3′-
diaminobenzidine reaction according to the manufacturer’s instructions (Vector Labs,
Burlingame, CA). The NBT/BCIP reaction precipitate was stable throughout the latter steps.
Retinas from BrdU-injected E5-E9 embryos were dissected, fixed in PFA, cryo-protected and
sectioned using a cryostat. The sections were processed for BrdU and TrkA double
immunohistochemistry. A polyclonal 1μg/ml anti-TrkA antibody (Lefcort et al., 1996; Oakley
et al., 1997) and the monoclonal BrdU antibody were diluted in PBS, 0.3% Triton X-100 and
5% normal serum to detect TrkA and BrdU. Secondary antibodies conjugated to fluorescein
isothiocyanate or Texas Red (Vector, Burlingame, CA) were diluted 1/100 and detected by
epifluorescence microscopy.
TUNEL analysis and TrkA immunohistochemistry
Normal retinas and retinas from injected embryos were fixed with PFA, cryoprotected with
30% sucrose, frozen and cut in a cryostat. Sections parallel to the optic axis, were processed
for terminal deoxynucleotidyl transferase TdT dUTP nick end labelling (TUNEL) according
to the manufacturer’s recommendations (Apoptosis detection system, Promega, Madison WI).
The anti-TrkA antibody was diluted 1/500 in equilibration buffer and was added during the
incubation with TdT transferase. Epifluorescence using Texas Red- and fluorescein
isothiocyanate-conjugated secondary antibodies, as well as the diaminobenzidine reaction was
used to detect the TrkA antibody. TUNEL-positive cells and TrkA-immunoreactive cells were
visualised directly with epifluorescence microscopy.
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Intraocular injections of NGF protein and antisense oligonucleotides
Intravitreal injections of NGF protein or phosphorothioate oligodeoxynucleotides (PONs) were
made into chicken embryo petri dish cultures (Selleck, 1996) or in ovo using a fine Hamilton
syringe. Petri dish cultures were used for injections of E10/E11 embryos, and E15/E16 embryos
were injected in ovo. Injected volume was 2 μl or 4 μl. Injections can lead to retinal detachment
and these were discarded from the series. 5 μg NGF protein in PBS was injected into the E10/
E11 and E15/E16 embryos, and analyses were made 1 or 2 days after injection. Vehicle was
injected as a control. Five antisense chicken NGF PONs, AS1-AS5, and two non-sense, NS1
and NS2, were previously designed and tested for their capacity to inhibit NGF expression in
COS cells (Hallböök et al., 1997; Hallböök et al., 2000). The AS1 PON that target the
translational initiation signal in the NGF mRNA was efficient in inhibiting NGF expression.
From our previous experiments we know that an effective concentration of PONs AS1 is 25
μM. To achieve this concentration in the in vivo retina, AS1 was labelled with 35S to a specific
activity of 1.5×107 CPM/μg and different amounts of AS1 were injected intraocularly. 24 hours
after injection, the embryos were dissected and the retina of the injected eye was rinsed and
homogenised before a sample was measured using a scintillation counter. Approximately 0.5
nmoles of AS1, NS1 or NS2 was injected at E10/E11, and 3 nmoles at E15/E16, to give a
retinal concentration of 25 μM. The efficacy of the injections was assessed by measuring NGF
protein levels in injected retinas (described below). PON penetration into the retina was
analysed using fluorescein-conjugated PONS as shown previously (Catsicas et al., 1995; Osen-
Sand et al., 1993). Unspecific tissue effects were tested by studying cell and fibre layers using
Nissl staining, TUNEL and SNAP25 immunohistochemistry after injection of antisense and
non-sense PONs at increasing amounts. No such effects were seen when injecting PONs giving
a retinal concentration of 25 μM. Minor effects such as vacuolisation and regional retinal
detachment could be seen when amounts of PONs corresponding to retinal concentration more
than 140 μM were injected. Eyes were dissected 1 or 2 days after injection and sections were
processed for TrkA and TUNEL analyses.
Enzyme immunoassay for NGF
NGF protein levels were measured in normal and PON-injected E11–E12 retinas using a
fluorimetric two-site sandwich enzyme immunoassay with anti-βNGF antibody conjugated
with β-galactosidase (Korsching and Thoenen, 1987). 96-well microtiter plates for fluorimetry
were coated with 0.5 μg/ml monoclonal anti-βNGF antibody (Boehringer-Mannheim, 1008
226, clone 27/21) in 0.05 M NaHCO3 buffer pH 9.6, blocked with 1% BSA in the same buffer
and washed in Tris-buffered saline with 0.5% Tween-20 pH 7.4, as previously described
(Söderström et al., 1990). Control-wells were coated with 0.5 μg/ml normal mouse IgG in the
same buffer. Dissected retinas were homogenised in Tris-buffered saline pH 7.4, 0.5%
Tween-20, 0.1% BSA, 10 mM EDTA, 20 kallekrein units/ml aprotinin (Sigma, A1153) and
0.1 mM phenyl-methyl-sulfonyl-fluorid (Boehringer-Mannheim). Twofold sample dilutions
in Tris-buffered saline with 0.1% BSA and 0.5%Tween-20 were applied onto the prepared
plates and incubated at 4°C overnight. Mouse NGF diluted in the same buffer served as a
standard (Söderström et al., 1990). 2.5 ng/ml β-galactosidase-conjugated anti-NGF antibody
in Tris-buffered saline, 2 mM MgCl2, 0.05% Tween-20 and 0.1% BSA was added to the plates,
which were incubated over night at 4°C. The next day they were washed in Tris-buffered saline
with 0.5% Tween-20 as previously described. 200 μl/well of 97.5 μM methylumbelliferyl-β-
galactoside (Sigma, M1633) in 0.05 M phosphate buffer pH 7.2 with 1 mM MgSO4, 0.2 mM
MnSO4, 2 mM EDTA and 0.05% azide was used as a substrate for β-galactosidase.
Fluorescence was detected in a MicroFluor™ Reader (Dynatech Laboratories, VI 22021) after
1 hour and after 24 hours. Data were processed and analysed as previously described in detail
(Söderström et al., 1990).
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Determination of cell number and density
The number of cells was counted in the central region of a retinal section using microscopy at
high magnification in four microscopic fields, two on both sides of the optic nerve exit. Four
sections from one retina were counted and an average number was calculated for a particular
retina. Cell density was used when retinas from different ages were compared. The density was
calculated by dividing the cell number with the retinal area of the counted region. The method
was modified from (Dutting et al., 1983). At least four different animals (n=4), subjected to
the same experimental treatment, were analysed, and the mean values and standard deviations
were calculated. Significance was calculated using the unpaired t-test.
RESULTS
NGF- and TrkA-expressing cells are postmitotic
We have used nonradioactive in situ hybridisation analysis to study expression of NGF and
TrkA mRNA in the developing avian retina. In situ hybridisation was used to be certain that
the sites of synthesis were studied. Immunohistochemistry for NGF on avian tissue does not
give reproducible results with any anti-NGF antibody that we have tested.
Immunohistochemistry for TrkA using an anti-avian TrkA antibody gives reproducible results
that correlate with in situ data. The very first cells labelled for NGF mRNA were detected in
the central part of the E5.5–E6 (stage 28) retina. These cells were located close to the vitreal
side of the neuroepithelium (Fig. 1A–F). The pattern changed with time and at E6–6.5 the cells
were dispersed over the neuroepithelium. At E7, labelled cells were found lined up in the
external part of the neuroepithelium, now identifiable as external part of the INL. This change
proceeded peripherally in the retina as shown in Fig. 1C. Analysis of BrdU incorporation and
NGF mRNA expression was used to study whether the early NGF-expressing cells were
postmitotic or not. Cells that were co-labelled for NGF mRNA and BrdU could not be found
in E6 or E7 retinas (Fig. 1E, I), suggesting that NGF synthesis commences after the completion
of the last S-phase and cell division. The location of the NGF-expressing cells in the external
part of the E7 INL suggested that these cells be of the horizontal cell type.
In an attempt to identify the early NGF-expressing cells, we labelled retinas for NGF and Brn3a
mRNA expression using a double in situ hybridisation protocol. Brn3a is a transcription factor
belonging to the Brn3 subfamily of POU class IV transcription factors and is expressed by
ganglion cells in the developing chicken retina (Lindeberg et al., 1997). Cells that seemed to
be labelled only for NGF or possibly co-labelled for NGF and Brn3a (Fig. 1F, G) could be
found on the vitreal side of the E5.5–E6 neuroepithelium. These results were not fully
conclusive because of the high density of Brn3a-labelled cells in the prospective ganglion cell
layer, together with the relatively thick sections that were used. However, the dispersed NGF-
labelled cells in the E6–E6.5 neuroepithelium were not co-labelled for Brn3a mRNA (Fig. 1F,
G) and by E7, the patterns of NGF and Brn3a labelling were completely segregated (Fig. 1J,
K).
We have previously shown that TrkA is expressed in the retina and the first cells are found in
the central region of the E5.5–E6 embryonic retina (Hallböök et al., 1996; Karlsson et al.,
1998). We combined BrdU incorporation with immunohistochemistry for TrkA and BrdU and
the results showed that TrkA cells were not co-labelled for BrdU (Fig. 1L).
NGF and TrkA mRNA is co-expressed in horizontal cells but not amacrine cells
TrkA expression is confined to both horizontal and amacrine cells in the E7–E13 retina (Figs
1M, N, 2B). At later ages, mainly horizontal cells express TrkA (Fig. 2F). The patterns of TrkA
and NGF expression overlap on the horizontal cells, but not on the amacrine cells, suggesting
that NGF and TrkA are co-expressed in horizontal cells (Fig. 2A, B, E, F). We used the double
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labelling in situ hybridisation protocol to study NGF and TrkA co-expression. The results from
analysis of E10, E12 and E17 retinas showed that labelling for NGF and TrkA mRNA could
be found over the same horizontal cell. Thus, NGF and TrkA mRNA are co-expressed by
horizontal cells (Fig. 2C, D, G, H) but not amacrine cells.
Many TrkA-expressing amacrine cells are TUNEL positive in the E11–E13 embryonic retina
Analysis of the density of TrkA-expressing horizontal and amacrine cells in E9–E17 retinas,
showed a decrease of TrkA-expressing amacrine cells around E10–E12, in contrast to the TrkA-
expressing horizontal cells that remained (Fig. 3). As a result of reduced thickness of the INL
during these stages, the density of horizontal cells increased (Fig. 3), even though the actual
number of TrkA-positive horizontal cells remained constant. TUNEL was used to monitor cell
death in the INL. There is a clear peak in the density of TUNEL cells around E10–E12. This
peak follows a period (E6–E8) with very few TUNEL cells. In addition, the peak comes after
the period with extensive proliferation (BrdU incorporation) in the early retina (Fig. 3). The
peak also coincides with the reduction of TrkA-expressing amacrine cells. The combination
of TUNEL and TrkA immunohistochemistry was used to study if this reduction was due to
cell death. At E9, no cells were co-labelled by TrkA and TUNEL (Fig. 4A). However, at E10–
E13, numerous TrkA immunoreactive cells with a typical neuronal and amacrine-like
morphology were labelled with TUNEL (Fig. 4B), suggesting that TrkA-expressing amacrine
cells die. The density of TrkA and TUNEL-amacrine cells peaked at E11 and this timepoint
coincides with the major peak of TUNEL-cells in the INL (Fig. 3). Notably, no TUNEL was
found at any time on TrkA-labelled cells with horizontal cell morphology and location (Fig.
4A–C), suggesting that cell death among the TrkA-expressing horizontals is very rare or even
absent.
Exogenous NGF supports TrkA amacrine cell survival
NGF protein was injected into the eye of E10/E11 embryos to analyse if NGF could support
the TrkA-expressing amacrine cells that would otherwise die. The number of TrkA amacrines
and horizontals were counted on sections and the density of TrkA amacrine cells increased
after NGF injections compared with vehicle injection (Fig. 5B). In addition, the density of cells
that were positive for both TrkA immunoreactivity and TUNEL was determined. Very few
TrkA and TUNEL amacrine cells could be found after NGF injection compared with normal
and vehicle-treated retinas (Fig. 4B, F). The density of double-labelled amacrine cells
decreased from approximately 35 to less than 5 cells/mm2 showing that NGF could counteract
cell death of the TrkA immunoreactive amacrine cells (Fig. 5B). NGF was also injected into
the E15/E16 eye with analysis the day after. Very few TUNEL cells can be found in any part
of the INL at this age and the added NGF had no effect on the density of those cells (Fig. 4K,
L). However, the added NGF protein distorted the structure of TrkA immunoreactive arceform
horizontal dendrites as shown in Fig. 4K, L. Injection of vehicle did not affect the cells.
Antisense NGF PON reduce NGF levels and cause death of TrkA-expressing horizontal cells
The fact that NGF is expressed only by the surviving horizontal cells, which also express TrkA
receptors and that added NGF can counteract the death of TrkA amacrine cells, suggest that
NGF could be a survival factor for the TrkA horizontal cells. To further test this hypothesis,
we blocked the endogenously produced NGF and analysed survival of TrkA horizontal cells.
We have previously shown that antisense oligonucleotides to the chicken NGF mRNA can
block NGF protein synthesis (Hallböök et al., 1997; Hallböök et al., 2000). We injected
antisense (AS1) and non-sense (NS1 or NS2) PONs into eyes of E10/E11 and E15/E16
embryos. E10/E11 is immediately before and E15/E16 is immediately after the cell death peak
in the INL. Injections of 0.5 nmoles or 3 nmoles AS1 or NS PONs (25 μM) did not cause any
unspecific tissue effects as shown by TUNEL, Nissl staining and SNAP25
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immunohistochemistry (not shown). The levels of NGF protein were analysed in the normal
and AS1 or NS PONs treated E11–E12 retina using an enzyme immunoassay. E12 retina was
shown to contain approximately 0.4 ng NGF/g wet tissue. Treatment with AS1 PON decreased
the NGF levels significantly when compared with normal and NS PON-treated retina (Fig.
5A). The histology of retinas from injected eyes were subsequently analysed in a similar way
as after the NGF injections.
The density of TrkA-expressing amacrine cells was in the same range in the AS1- or NS-treated
retinas, as well as untreated E11–E12 retinas. The situation was similar for TrkA-and TUNEL-
positive amacrine cells (Fig. 5B). However, when looking at the TrkA-expressing horizontal
cells in AS1 treated E11/12 retina, many cells showed TUNEL. These double-labelled cells
were indeed conspicuous, as no such cells were found in normal or control retina (Figs 4B, D,
E, 5C). Approximately half of the TrkA-expressing horizontals were TUNEL positive. A
significant reduction of the TrkA horizontal cell density was also seen in the AS1-treated retina
(Fig. 5C). The absence of effect by AS1 on the TrkA amacrine cell density could be considered
as a control for unspecific effects by the PON treatment.
Treatment with neither AS1 nor NS PONs caused any effect on the density of TrkA or TUNEL
cells in the E16/E17 retina (Fig. 4G–L). However, treatment with AS1, but not with NS PON,
caused a disruption of the TrkA immunoreactive arceform horizontal dendrites as shown in
Fig. 4G, H.
DISCUSSION
In this work we have studied cells that express NGF and TrkA in the developing avian retina.
The results show that horizontal cells co-express NGF and TrkA, while TrkA-expressing
amacrine cells do not express NGF. The majority of the TrkA-expressing amacrine cells die
during the period of cell death in the INL. Intraocular injections of NGF protein rescued the
dying amacrine cells and injection of antisense NGF oligonucleotides that blocked NGF
synthesis, caused death among the TrkA-expressing horizontal cells, which normally survive.
Based on these results, we suggest a role for NGF in supporting the survival of horizontal cells
in the developing retina.
Independent studies have shown that NGF is expressed in the avian retina (Ebendal and
Persson, 1988; Frade et al., 1996; Goedert, 1986; Hallböök et al., 1996; Large et al., 1989).
Frade et al. found NGF mRNA in the E4 retina using RT-PCR (Frade et al., 1996). We did not
detect any NGF mRNA before E5.5–E6 (stage 28) in the developing optic cup, retina or tissue
associated with the retina. The first NGF-producing cells are located on the vitreal side of the
neuroepithelium. The pattern changes and labelled cells are dispersed over the
neuroepithelium; by E6.5–E7 they are found lined up in the external part of the neuroepithelium
(Fig. 1B–F). The change in pattern coincides with neurogenesis and migration of neuroblasts
in the developing retina (Prada et al., 1991; Spence and Robson, 1989). Neuroblasts complete
their last S-phase when located in the vitreal part and migrate subsequently to the ventricular
(external) part of the neuroepithelium where they divide (Prada and Ramírez, 1983). No
labelling for BrdU could be found in the first NGF-labelled cells, suggesting that these NGF
expressing cells are postmitotic. They are likely to represent precursor cells that have completed
their last division and migrate freely in the neuroepithelium. No co-labelling of BrdU and NGF
could be found at later times of development. Our results show that the early dispersed NGF-
expressing cells were not labelled for Brn3a mRNA, suggesting that those cells meet a different
fate from the ganglion cells. However, co-labelling for Brn3a and NGF mRNA could not be
dismissed in the earliest cells located on the vitreal side of the retina, and the identity of this
early NGF producing cell population remains to be determined.
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Similarly to NGF expression, TrkA expression commences at E5.5–E6 as shown using
immunohistochemistry, in situ hybridisation and RNase protection assay (Karlsson et al.,
1998). The results disagree with those by Frade et al. who could not detect any TrkA mRNA
until E14 using RT-PCR (Frade et al., 1996). We know that there are two types of TrkA-
expressing cells: horizontal cells and amacrine cells. Both are separately distinguishable in the
E6.5–E7 retina. There are three identifiable subtypes of horizontal cells in the avian retina
(Génis-Gálvez et al., 1979) and the TrkA horizontal cell is similar to the axon-less
‘candelabrum-shaped’ subtype (Karlsson et al., 1998). In this study we show that NGF and
TrkA are co-expressed in these horizontal cells (Fig. 2). We could not detect any TrkA
expression in the E5.5–E6 prospective ganglion cell layer where the early NGF-expressing
cells was found, suggesting that NGF expression might be initiated before TrkA expression.
Furthermore, the TrkA amacrine cells do not express NGF, indicating independent activation
of NGF and TrkA expression. Activating signals are unknown, but both intrinsic properties
and extrinsic cues can direct cell phenotypes (Cepko, 1999; Cepko et al., 1996).
The appearance of TUNEL-labelled TrkA-immunoreactive amacrine cells (Fig. 3) clearly
correlates with the reduction of TrkA-expressing amacrine cells in the INL, suggesting that
these cells undergo cell death. Addition of NGF protein increased the number of TrkA-
immunoreactive amacrine cells and reduced the number of cells that were co-labelled for
TUNEL and TrkA, showing that these cells can respond to NGF stimulation with survival (Figs
4F, 5B). Injection of AS1 PONs that reduced the levels of NGF in the retina (Fig. 5A) did not
affect the TrkA amacrines. In spite of the close source of horizontal cell-produced NGF, the
majority of TrkA-expressing amacrine cells die. Thus, NGF is most likely not released from
the horizontal cells in a fashion that makes it available for the TrkA amacrines. This is in
agreement with the low levels of NGF in the retina (0.4 ng/g, Fig. 5A) as compared to those
found in (for example) the rat hippocampus, which contains 3–8 ng/g (Henriksson et al.,
1992).
A few TrkA-immunoreactive amacrine cells indeed survive and are found in the adult retina
(Karlsson et al., 1998; Karten et al., 1995). If their survival is supported by NGF or by other
factors such as neurotrophin 3 (Bovolenta et al., 1996; Hallböök et al., 1996) is not clear.
Contacts between horizontals and amacrines have not been described, but NGF from the
horizontal cells could be delivered anterogradely by bipolar cells, which contact both
horizontals and amacrines, as has been shown for neurotrophins in retinal ganglion cells (von
Bartheld et al., 1996). However, we could not see any effects of the AS1 on the TrkA amacrine
cells, which argues for involvement of other factors.
The horizontal cells co-express TrkA and NGF, suggesting an autocrine mode of action for
NGF. It is not clear if co-expression of NGF and TrkA is required for NGF action, or if the
NGF can be shared with neighbouring TrkA-expressing cells. A subpopulation of rat adult
dorsal root ganglion neurones co-express TrkB and brain-derived neurotrophic factor, and their
survival is supported by brain-derived neurotrophic factor in a similar autocrine loop (Acheson
et al., 1995). We could not detect any cell death among the horizontal cells in the normal retina
at any stage of development. However, if the NGF levels were reduced by AS1 PON injection
in the E10–E12 retina, several of these cells died (Figs 4D, 5C). Thus, the cells are programmed
for death, but they all survive. Our results clearly show that NGF that is produced by the
horizontal cells themselves, supports their survival. NGF functions in this case as a survival
factor, but is not synthesised and released from the horizontal cells in a fashion that leads to
competition for NGF among the horizontal cells. Thus, it is not acting as a ‘classical’
neurotrophic factor (Lewin and Barde, 1996), which is produced in limited amounts. Later in
development, the cells become independent of NGF for survival: injections of the inhibiting
PONs at E15/E16 did not cause cell death. A conclusion from this, is that the final number of
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TrkA horizontal cells is determined by how many cells are produced. In contrast, cell death
and selective survival determine the final number of TrkA amacrine cells.
Horizontal cells are interneurones that form contacts with bipolar cells, photoreceptors as well
as other horizontal cells. The TrkA horizontal cells develop arceform dendrites with knob-like
structures in the outer plexiform layer, which are shared by neighbouring TrkA horizontal cells
(Karlsson et al., 1998). The knobs are located close to the photoreceptors and are likely to be
part of synaptic contacts with the photoreceptors. Horizontal cell synapses are known to
undergo morphological changes in association with increased synaptic activity, with formation
of spinules protruding into the photoreceptors (Wagner and Djamgoz, 1993). Injection of the
inhibiting AS1 PON during horizontal dendrite formation (E10–E12), not only caused cell
death but also disrupted the structure of the arceform dendrites. This effect was clearer in the
E15–E17 retina. The structure of the arceform dendrites was also affected by the NGF
injections, even though the effect was less severe and dendrites were distorted but not disrupted.
As shown by TrkA immunohistochemistry, TrkA receptors are located on both the soma and
neurites (Karlsson et al., 1998), with the most intense TrkA immunoreactivity on dendrites and
knob-like structures. TrkA intensity on dendrites increased with age, suggesting that the
receptors have a specific subcellular distribution. The results of the present study and our
previous results, showing that NGF mRNA levels are modulated by light in the 5-day-old chick
retina (Hallböök et al., 1996), are consistent with the general role for neurotrophins in synaptic
plasticity (McAllister et al., 1999). Our results suggest two separate roles for NGF: support of
survival and a role in horizontal cell plasticity.
Lately, attention has been focused on the role of NGF in inducing cell death via the p75 receptor.
The work by Frade and Barde (Frade and Barde, 1998) suggests that NGF and p75 interact to
induce early ganglion cell death in central regions of the avian retina. The cellular source of
NGF was shown to be macrophages (microglial precursors) that enter the optic cup at E3 and
migrate into the retina where they present NGF for certain cells that die. It is still debated if
these cells actually cause the death or if they are attracted by dying cells during development
(Cuadros et al., 2000; Cuadros and Navascues, 1998; Marin-Teva et al., 1999). Recently, it
was shown that experimentally increased naturally occurring neuronal death in the avian
isthmo-optic nucleus attracts macrophages/microglial precursors (Cuadros et al., 2000). We
could not detect any NGF mRNA expression in the chick retina that was temporally or spatially
associated with the early retinal cell death.
In conclusion, NGF supports the survival of TrkA-expressing avian horizontal cells in an
autocrine mode of action during the late phase of cell death in the E10–E12 retina. The cells
co-express TrkA and NGF, and the role for NGF is to maintain the TrkA-expressing horizontal
cells. The population of TrkA-expressing amacrine cells is not supported by NGF and
undergoes cell death during the late cell death phase in the INL. Our results also suggest that
NGF plays a role in horizontal cell plasticity.
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Fig. 1.
Analysis of early NGF and TrkA expression in embryonic retina. mRNA expression was
analysed using in situ hybridisation analysis. Micrographs show cross sections of central region
retina and are oriented with vitreal side facing downwards. (A) Analysis of E3 retina. No
labelling was found. (B) Analysis of NGF mRNA expression in E5.5–E6 central retina. (C)
Overview of a section of an E7 retina with labelling for NGF mRNA. Ventricular/external side
(ext), vitreal side (vitr) and area of retina with dispersed NGF cells (disp). Note that the pigment
epithelium is not included. b, f and i indicate regions of the retina that are representative for
B, F and I, respectively. (D) E7 control (ctr) retina hybridised with sense probe for NGF mRNA.
(E) Combination of NGF in situ hybridisation and BrdU immunohistochemistry analyses of
E6 retina. (F) Analysis of NGF and Brn3a mRNA expression in the E6.5 retina using double
in situ hybridisation. (G) High magnification of cells shown in F (NGF, red and Brn3a, blue).
(H) E6.5 control retina hybridised with sense probes for NGF and Brn3a mRNA. (I)
Combination of NGF in situ hybridisation and BrdU immunohistochemistry analyses of E7
retina. (J) Analysis of NGF and Brn3a mRNA expression in E7 retina. (K) Analysis of Brn3a
Karlsson et al. Page 13
Development. Author manuscript; available in PMC 2009 July 14.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
mRNA expression in E7 retina. (L) Analysis of TrkA (fluorescein) and BrdU immunoreactivity
(Texas Red) in the E6.5 retina. (M) In situ hybridisation and (N) immunohistochemical
analyses of TrkA expression in E7 retina. Scale bar in A, 75 μm for A; in B, 80 μm for B, D–
F, I–N; in C, 200 μm for C; in G, 25 μm for G; in H, 50 μm for H.
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Fig. 2.
NGF and TrkA mRNA expression in the E12 and E17 developing chicken retina. In situ
hybridisation analysis of NGF and TrkA mRNA expression in E12 (A–D) and E17 retina (E–
H). Micrographs show cross sections of central region retina and sections are oriented with
vitreal side facing down. (A, E) Analysis of NGF mRNA expression. (B, F) Analysis of TrkA
mRNA expression. (C, D, G, H) Double-in situ hybridisation analysis of NGF (red) and TrkA
(blue) mRNA expression. (C, G) High-power magnification of the regions shown in D, H,
respectively. Arrows indicate double-labelled cells. gcl, ganglion cell layer; inl, inner nuclear
layer. Scale bar in A, 50 μm for A, B, D–F, H; in C and G, 25 μm.
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Fig. 3.
Number of TUNEL, TrkA and BrdU immunoreactive cells in the inner nuclear layer of E5-
E18 retina. Cell density plotted against the age of the developing retina. The number of cells
was counted in cross sections of central retina and density was calculated as number of cells
per mm2 of transverse section of inner nuclear layer. The size, including thickness of the retina,
increased from E4 to E6 as a result of extensive cell proliferation, decreased cell death and
increased cell size. This resulted in a drop of cell density between E5 and E6. TrkA-expressing
amacrine cells (AC) and horizontal cells (HC) were counted from E9 as earliest age when those
cells are clearly distinguishable. The increase in TrkA-labelled horizontal cell density seen
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after E10 is a result of decreased thickness of the inner nuclear layer and not a result of more
cells. Error bars are s.d. (n=4).
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Fig. 4.
TrkA immunohistochemistry in combination with TUNEL in normal and injected retinas. TrkA
immunohistochemistry was combined with TUNEL on sections of retina. (A–K) TrkA
immunoreactivity is shown in red (Texas Red) and TUNEL in green (fluorescein
isothiocyanate). Analysis of normal E9 (A), E12 (B) and E17 (C) retinas. (D–F) Analysis of
E12 retinas after intraocular injection of AS1 antisense NGF PON (D), control PON (E) and
NGF (F). (G–L) Analysis of E17 retina after intraocular injection of AS1 antisense NGF PON
(G, H), control PON (I, J) and NGF (K, L). TrkA immunoreactivity is visualised using
epifluorescence (G, I, K), as well as using the diaminobenzidine reaction (H, J, L). Arrowheads
in B, D, E indicate TrkA amacrine; small arrows in D indicate TrkA horizontal cells that are
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labelled with TUNEL. Asterisks in G, H indicate the disrupted horizontal dendritic structures.
gcl, ganglion cell layer; inl, inner nuclear layer; prl, photoreceptor layer. Scale bar in A, 50
μm for A–C; in D, 50 μm for D–F; in G 25 μm for G–L.
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Fig. 5.
Effect on NGF protein levels and density of TrkA amacrine and horizontal cells in E12 retinas
after intraocular injections of antisense NGF PON or NGF protein. (A) The level of NGF
protein was analysed using an enzyme immunoassay in normal (untreated, n=4), AS1 antisense
NGF PON- (AS1, n=5) and nonsense PON- (ctr, n=5) treated retinas. Density of amacrine cells
(B) and horizontal cells (C) in E12 retina after treatment with AS1 (n=4), nonsense (ctr, n=4)
and NGF protein (NGF, n=4). Stippled bars indicate the total number of TrkA immunoreactive
cells and white bars indicate TrkA-and TUNEL-positive cells. Graphs show mean densities
±s.d.
*P=0.02, ***P<0.0005 (t-test). White bars for ctr and NGF in C are zero.
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